Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 31INDUSTRY 16NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia 3Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Lymphatic Diseases 2Leukemia, Myeloid 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2Leukemia, B-Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Diseases 2Bone Marrow Diseases 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Sarcoma, Alveolar Soft Part 1Primary Myelofibrosis 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 15Vincristine 13Prednisone 13Rituximab 12Doxorubicin 11Etoposide 10Radiotherapy 9Methotrexate 6Filgrastim 6Cytarabine 6Gemcitabine 5Cisplatin 5VAP-cyclo protocol 4Granulocyte Colony-Stimulating Factor 4ibritumomab tiuxetan 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Leucovorin 3Immunohistochemistry 3Ifosfamide 3Gene Expression Profiling 3Dexamethasone 3pegfilgrastim 2merphos 2fludarabine 2axicabtagene ciloleucel 2Watchful Waiting 2Specimen Handling 2Mesna 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large B-Cell, Diffuse × fludarabine × Clear all
NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

SWOG Cancer Research Network

Phase 2 Recruiting
396 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡